← Back to Analyst Consensus 
HALO Buy
HALOZYME THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 8, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Oct 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 7, 2026 | Leerink Partners | upgrade | Market Perform → Outperform | — | 51% |
| Aug 7, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 7, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 21, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 12, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Apr 29, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 19, 2026 | Benchmark | maintain | Buy → Buy | $90 | 54% |
| Feb 19, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $75 | 54% |
| Jan 8, 2026 | TD Cowen | maintain | Buy → Buy | $90 | 54% |
| Dec 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $90 | 44% |
| Nov 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $90 | 44% |
| Nov 18, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $56 | 54% |
| Nov 4, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $92 | 47% |
| Oct 27, 2025 | JP Morgan | maintain | Neutral → Neutral | $65 | 54% |
| Oct 20, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $79 | 54% |
| Oct 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $90 | 44% |
| Oct 14, 2025 | Leerink Partners | upgrade | Underperform → Market Perform | $70 | 51% |
| Oct 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $90 | 44% |
| Sep 24, 2025 | Benchmark | maintain | Buy → Buy | $90 | 54% |
| Sep 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $85 | 44% |
| Aug 18, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $80 | 54% |
| Aug 7, 2025 | JP Morgan | maintain | Neutral → Neutral | $63 | 54% |
| Aug 6, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $91 | 53% |
| Aug 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $75 | 44% |
| Aug 6, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $75 | 54% |
| Jul 16, 2025 | JP Morgan | maintain | Neutral → Neutral | $60 | 54% |
| May 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $72 | 44% |
| May 14, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $62 | 54% |
| May 13, 2025 | Leerink Partners | downgrade | Market Perform → Underperform | $47 | 51% |
| May 7, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $73 | 54% |
| May 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $65 | 54% |
| Apr 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $72 | 44% |
| Apr 21, 2025 | JP Morgan | maintain | Neutral → Neutral | $58 | 54% |
| Mar 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $0 | 44% |
| Feb 20, 2025 | Benchmark | reiterate | Buy → Buy | $75 | 54% |
| Feb 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $72 | 44% |
| Feb 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $70 | 44% |
| Jan 13, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $57 | 54% |
| Jan 10, 2025 | Piper Sandler | maintain | Neutral → Neutral | $53 | 54% |
| Jan 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $70 | 44% |
| Dec 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $68 | 44% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $68 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $68 | 44% |
| Nov 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $68 | 44% |
Price Target Trend
May 13, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days